Odesivimab: Side Effects, Uses & Monitoring
Facts extracted from current FDA product labeling for Odesivimab. Educational only — not medical advice.
Labeled uses
INMAZEB is indicated for the treatment of infection caused by Orthoebolavirus zairense in adult and pediatric patients, including neonates born to a mother who is RT-PCR positive for Orthoebolavirus zairense infection [see Dosage and Administration (2.2) , and Clinical Studies (14) ] .
Source: FDA labeling via NIH DailyMed (set 0536b6fe…). Not affiliated with FDA or NIH.
Medical disclaimer: Always consult a qualified healthcare professional about any medication.